Having recently taken on tax-related engagements for Yahoo! Inc. and Darden Restaurants Inc., lawyers from Skadden, Arps, Slate, Meagher & Flom have also scored a role on Pfizer Inc.’s controversial $152 billion pharmaceutical industry union with Allergan Inc.
The Am Law Daily recently reported on the dozen or so firms behind the mega-deal, whose inversion structure could save Pfizer roughly $2.1 billion in taxes. Skadden is serving as corporate and tax counsel to the New York-based acquirer, which would move its headquarters to tax-friendly Ireland if it succeeds in sidestepping regulatory and political scrutiny and absorbs Dublin-based Allergan in early 2016.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
